Terms: = Colorectal cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Clinical Outcome
6 results:
1. A concise review on the role of BDNF-AS in human disorders.
Ghafouri-Fard S; Khoshbakht T; Taheri M; Ghanbari M
Biomed Pharmacother; 2021 Oct; 142():112051. PubMed ID: 34426254
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma.
Xie SC; Zhang JQ; Jiang XL; Hua YY; Xie SW; Qin YA; Yang YJ
Cell Death Dis; 2020 Aug; 11(8):676. PubMed ID: 32826865
[TBL] [Abstract] [Full Text] [Related]
3. Enhancer of Zeste Homolog 2 in colorectal cancer Development and Progression.
Bremer SCB; Conradi LC; Mechie NC; Amanzada A; Mavropoulou E; Kitz J; Ghadimi M; Ellenrieder V; Ströbel P; Hessmann E; Gaedcke J; Bohnenberger H
Digestion; 2021; 102(2):227-235. PubMed ID: 31694013
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of ezh2 expression in patients with oesophageal cancer: a meta-analysis.
Wang Y; Gao F; Zhao M; Li B; Xing D; Wang J; Yang Y
J Cell Mol Med; 2016 May; 20(5):836-41. PubMed ID: 26859127
[TBL] [Abstract] [Full Text] [Related]
5. Inferior vena cava resection with hepatectomy: challenging but justified.
Malde DJ; Khan A; Prasad KR; Toogood GJ; Lodge JP
HPB (Oxford); 2011 Nov; 13(11):802-10. PubMed ID: 21999594
[TBL] [Abstract] [Full Text] [Related]
6. An ezh2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients.
Crea F; Fornaro L; Paolicchi E; Masi G; Frumento P; Loupakis F; Salvatore L; Cremolini C; Schirripa M; Graziano F; Ronzoni M; Ricci V; Farrar WL; Falcone A; Danesi R
Ann Oncol; 2012 May; 23(5):1207-1213. PubMed ID: 21926398
[TBL] [Abstract] [Full Text] [Related]
